1215040

BioReliance Corporation — FEI 1122041

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 4, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rockville, MD (United States)